Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

Vasohibin‐1 (VASH1) is a VEGF‐inducible endothelium‐derived angiogenesis inhibitor, and vasohibin‐2 (VASH2), its homolog, exhibits proangiogenic activity. VASH2 is expressed by various cancer cells and accelerates tumor angiogenesis and progression. VASH2 was recently shown to exhibit tubulin carbox...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyanagi, Takahiro, Saga, Yasushi, Takahashi, Yoshifumi, Tamura, Kohei, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Takei, Yuji, Urabe, Masashi, Mizukami, Hiroaki, Fujiwara, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026928/
https://www.ncbi.nlm.nih.gov/pubmed/33710778
http://dx.doi.org/10.1002/cam4.3841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026928/
https://www.ncbi.nlm.nih.gov/pubmed/33710778
http://dx.doi.org/10.1002/cam4.3841

Ejemplares similares